Who owns Helus Pharma Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of HELP from SEC Form 13F filings across 109 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 109 institutions disclosed 26.6M shares of Helus Pharma Inc. worth $327.6M — about 76.5% of shares outstanding; the largest disclosed holder is ADAGE CAPITAL PARTNERS GP, L.L.C.. Source: SEC Form 13F filings, parsed by EvidInvest.
109
13F holders
$327.6M
value, 2026 filers
76.5%
of shares outstanding (26.6M sh)
39
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of HELP's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 5.3M | $64.5M | 0.1% | 15.1% | +71.6% |
| 2 | D. E. Shaw & Co., Inc. | 2.8M | $35.0M | 0.0% | 8.2% | +4512.3% |
| 3 | ACORN CAPITAL ADVISORS, LLC | 1.5M | $18.9M | 5.2% | 4.4% | 0.0% |
| 4 | Rosalind Advisors, Inc. | 1.4M | $17.1M | 5.5% | 4% | -29.1% |
| 5 | TWO SIGMA INVESTMENTS, LPNEW | 1.3M | $16.5M | 0.0% | 3.8% | new |
| 6 | PRICE T ROWE ASSOCIATES INC /MD/NEW | 1.3M | $15.6M | 0.0% | 3.6% | new |
| 7 | Point72 Asset Management, L.P. | 1.2M | $15.1M | 0.0% | 3.5% | +1054.6% |
| 8 | DCF Advisers, LLC | 1.0M | $12.3M | 2.8% | 2.9% | -30.1% |
| 9 | Nan Fung Group Holdings Ltd | 987,222 | $12.1M | 8.1% | 2.8% | 0.0% |
| 10 | Sio Capital Management, LLC | 561,289 | $6.9M | 1.3% | 1.6% | -56.8% |
| 11 | JPMORGAN CHASE & CO | 555,499 | $7.1M | 0.0% | 1.6% | +133.6% |
| 12 | MARSHALL WACE, LLPNEW | 518,322 | $6.4M | 0.0% | 1.5% | new |
| 13 | Integral Health Asset Management, LLCNEW | 500,000 | $6.1M | 0.4% | 1.4% | new |
| 14 | Ikarian Capital, LLC | 487,575 | $6.0M | 0.6% | 1.4% | +268.9% |
| 15 | ROYCE & ASSOCIATES LP | 430,094 | $5.3M | 0.0% | 1.2% | +85.3% |
| 16 | Y-Intercept (Hong Kong) LtdNEW | 424,276 | $5.2M | 0.1% | 1.2% | new |
| 17 | SPHERA FUNDS MANAGEMENT LTD. | 388,151 | $4.8M | 0.7% | 1.1% | -76.1% |
| 18 | AdvisorShares Investments LLC | 387,702 | $4.8M | 0.6% | 1.1% | +32.5% |
| 19 | Knott David M Jr | 370,000 | $4.5M | 2.5% | 1.1% | 0.0% |
| 20 | GREAT POINT PARTNERS LLCNEW | 320,952 | $3.9M | 0.9% | 0.9% | new |
| 21 | Blue Owl Capital Holdings LP | 288,282 | $3.5M | 0.6% | 0.8% | +381.2% |
| 22 | VOLORIDGE INVESTMENT MANAGEMENT, LLCNEW | 287,440 | $3.5M | 0.0% | 0.8% | new |
| 23 | PICTON MAHONEY ASSET MANAGEMENTNEW | 256,593 | $3.2M | 0.0% | 0.7% | new |
| 24 | JANE STREET GROUP, LLC | 247,809 | $3.0M | 0.0% | 0.7% | -11.8% |
| 25 | UBS Group AG | 236,482 | $2.9M | 0.0% | 0.7% | +8.1% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.